SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-029261
Filing Date
2022-12-16
Accepted
2022-12-16 16:15:48
Documents
13
Period of Report
2022-12-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbyi20221216_8k.htm   iXBRL 8-K 24465
  Complete submission text file 0001437749-22-029261.txt   155434

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20221213.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20221213_def.xml EX-101.DEF 11533
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20221213_lab.xml EX-101.LAB 15415
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20221213_pre.xml EX-101.PRE 11689
7 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20221216_8k_htm.xml XML 2573
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 221468147
SIC: 2834 Pharmaceutical Preparations